University of Cincinnati
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Cincinnati sits in the top decile of US sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count).
University of Cincinnati: 245 sponsored US clinical trials, 34 recruiting.
University of Cincinnati sponsors 245 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 172 completed. 65 of these trials are in Phase 3-4 (later-stage) and 56 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 9 trials.
Top-decile sponsor footprint
University of Cincinnati ranks in the top decile of sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
172 of 189 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
245 total, page 5 of 5
Efficacy and Safety of Sirolimus in LAM
NCT00414648
Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
NCT00394095
Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
NCT00403650
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
NCT00393978
Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
NCT00607789
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
NCT00601198
End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
NCT00374582
Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome
NCT00375973
Use of Focalin for Fatigue in Sarcoidosis
NCT00361387
Nutritional Supplementation in Cognitive Aging
NCT00599508
Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV
NCT00545558
Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
NCT00374803
Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor
NCT00306462
Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
NCT00264797
Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function
NCT00662142
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00253747
Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection
NCT00885664
Impact of Health Literacy on Outcomes and Effectiveness of Shared Decision Making Programs in Patients With Chronic Diseases
NCT01083862
A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder
NCT00232414
Study to Determine the Effectiveness of Pillar Palatal Implants to Treat Obstructive Sleep Apnea
NCT00307957
Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
NCT00115804
Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts
NCT00374647
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)
NCT00249405
Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Testing on Outcomes
NCT00222352
The Paired Donation Consortium Paired Donation Program
NCT00374400
Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea
NCT00307944
Brief Intervention for Socially Anxious College Drinkers
NCT00872118
Effect of High Monounsaturated Fat Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes
NCT00622960
Use of Thalidomide in Chronic Uveitis
NCT00314665
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
NCT00078143
Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)
NCT00414921
Alcohol and Gender Effects on Stress Circuit Function
NCT00226694
A Nutrition Intervention to Lower Blood Pressure in Adolescents
NCT00431288
Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
NCT00250991
A Study of Quetiapine for the Treatment of Mood Disorders in Adolescents
NCT00221468
Interventional Management of Stroke (IMS) II Study
NCT00243906
Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
NCT00374231
Familial Intracranial Aneurysm Study II
NCT00071565
Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
NCT00352092
Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients
NCT00374283
Effects of a Ketogenic Diet on Body Weight and Cardiovascular Risk Factors
NCT00498394
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
NCT00031395
A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
NCT00363116
Nutrient Levels Alter Transplant Outcome
NCT00560014
Results of Ocular Compression and Suture Release in Trabeculectomy and Combined Surgery
NCT00327405
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 33 |
| Phase 3 | 19 |
| Phase 4 | 46 |
Therapeutic Areas
What is open in the University of Cincinnati pipeline
34 recruiting of 245 indexed (14% open); 172 completed (70%).
Phase mix: 65 late (III/IV) vs 56 early (I/II) (balanced across stages).
Top condition: Stroke (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Cincinnati: open-pipeline peers nationwide
Peers matched on 245 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 245 trials (± recruiting share)
- Shire · 245 trials · 0% recruiting
- State University of New York at Buffalo · 243 trials · 21% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- University of Massachusetts, Worcester · 240 trials · 13% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- BeiGene · 14% recruiting · 65 trials
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
Related
What to do with this University of Cincinnati page
245 registered trials is a research-attention snapshot, not an endorsement of University of Cincinnati or any single study.
- 34 of University of Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition University of Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Cincinnati pipeline card: 245 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.